Kindly MD, Inc. (NASDAQ: KDLY) is a U.S.-based healthcare technology company specializing in teledermatology services. The company operates an online platform that enables patients to receive remote consultations for a wide range of skin conditions, including acne, eczema, psoriasis, and rashes. Through a secure, asynchronous workflow, users submit photos and medical histories, and board-certified dermatologists review and diagnose cases, providing treatment plans and, when appropriate, electronic prescriptions.
In addition to its core direct-to-consumer offering, Kindly MD provides white-label teledermatology solutions for employer groups, health plans, telemedicine providers and retail pharmacy chains. These partnerships aim to expand access to dermatological care by integrating the Kindly MD platform into existing healthcare ecosystems, reducing patient wait times and lowering overall treatment costs.
Founded in 2016 and headquartered in New York, Kindly MD has focused on leveraging technology to improve the efficiency and reach of dermatological services across the United States. The company’s platform incorporates secure data handling, image analytics, and a network of licensed dermatologists to ensure consistent quality of care, while enabling scalability to serve diverse patient populations.
Kindly MD is led by a management team with experience in healthcare delivery, telemedicine operations and digital health innovation. The company trades publicly on the Nasdaq stock exchange under the ticker KDLY, reflecting its commitment to bringing remote skin-care solutions to both individual consumers and institutional partners.
AI Generated. May Contain Errors.
Free KDLY Stock Alerts